Professor, Elson S. Floyd College of Medicine, Washington State University
Naomi Chaytor, PhD, ABPP
What is your presentation about?
I will present data from several studies on the association between biomedical risk factors and cognitive decline in aging adults with type 1 diabetes. These data provide insights into ways providers can help patients thrive cognitively as they age, and how to identify and prevent adverse outcomes in those at risk for declining cognition.
What makes this topic important in 2022?
The great news is that people with type 1 diabetes are living longer than ever before thanks to advances in diabetes management. It is important that providers understand normal and pathological aging with T1D, in order to reduce cognitive complications and identify those at high risk.
How did you become involved with this area of diabetes research or care?
My research has always focused on risk and protective factors for cognitive impairment across various neurological and medical populations. When I was diagnosed with type 1 diabetes at age 35, I shifted my research focus to the role of cognition in type 1 diabetes. Shortly afterwards, I had an opportunity to contribute to a T1D Exchange study on risk factors associated with severe hypoglycemia in older adults and later collaborate with the DCCT/EDIC cognition group.
What are you most looking forward to at the 82nd Scientific Sessions?
Meeting the other presenters in my symposium, whose work I have admired for many years, will be a highlight. I am also looking forward to learning about diabetes research in areas adjacent to my own research focus, such as new advances in diabetes technology.